Last week the Centers for Medicare & Medicaid Services (CMS) issued the contract year 2024 changes to the Medicare Advantage and Medicare Prescription drug benefit program final rule, which will be published in the Federal Register on April 12. For CMS’ fact sheet, click here. For CMS’ press release, click here. For NCPA’s comments submitted in February 2023, click here. The final rule made the Medicare Limited Income Newly Eligible Transition (LI NET) program a permanent part of Medicare Part D, and it also expanded the low-income subsidies program under Part D as well. MA plans must now comply with national coverage determinations (NCD), local coverage determinations (LCD), and general coverage and benefit conditions included in traditional Medicare statutes and regulations as interpreted by CMS. CMS did not finalize its proposal of expanding the medication therapy management (MTM) program. Stay tuned for NCPA’s more comprehensive member summary of the final rule.
NCPA
